These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11751107)

  • 1. Pharmacokinetics and inflammatory fluid penetration of intravenous daptomycin in volunteers.
    Wise R; Gee T; Andrews JM; Dvorchik B; Marshall G
    Antimicrob Agents Chemother; 2002 Jan; 46(1):31-3. PubMed ID: 11751107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers.
    Kim A; Suecof LA; Sutherland CA; Gao L; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3941-6. PubMed ID: 18779352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics and penetration of BMS 284756 into an inflammatory exudate.
    Wise R; Gee T; Marshall G; Andrews JM
    Antimicrob Agents Chemother; 2002 Jan; 46(1):242-4. PubMed ID: 11751144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and tissue penetration of intravenously administered CGP 31608.
    Wise R; Webberley JM; Andrews JM; Ashby JP
    J Antimicrob Chemother; 1988 Jan; 21(1):85-91. PubMed ID: 3356625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin pharmacokinetics in adult oncology patients with neutropenic fever.
    Bubalo JS; Munar MY; Cherala G; Hayes-Lattin B; Maziarz R
    Antimicrob Agents Chemother; 2009 Feb; 53(2):428-34. PubMed ID: 19015332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study to determine the pharmacokinetics and inflammatory fluid penetration of two doses of a solid formulation of the hexetil prodrug of a trinem, sanfetrinem (GV 104326).
    Wise R; Andrews JM; Da Ros L; Child J; Mortiboy D
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1761-4. PubMed ID: 9257756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and inflammatory fluid penetration of clinafloxacin.
    Wise R; Jones S; Das I; Andrews JM
    Antimicrob Agents Chemother; 1998 Feb; 42(2):428-30. PubMed ID: 9527799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury.
    Mohr JF; Ostrosky-Zeichner L; Wainright DJ; Parks DH; Hollenbeck TC; Ericsson CD
    Antimicrob Agents Chemother; 2008 May; 52(5):1891-3. PubMed ID: 18299410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose.
    Wise R; Andrews JM; Ashby JP; Marshall J
    J Antimicrob Chemother; 1999 Nov; 44(5):701-4. PubMed ID: 10552990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid.
    Child J; Mortiboy D; Andrews JM; Chow AT; Wise R
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2749-51. PubMed ID: 8593013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis.
    Piva S; Di Paolo A; Galeotti L; Ceccherini F; Cordoni F; Signorini L; Togni T; De Nicolò A; Rasulo FA; Fagoni N; Latronico N; D'Avolio A
    Neurocrit Care; 2019 Aug; 31(1):116-124. PubMed ID: 30607829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Drug-Drug Interaction Potential of Daptomycin in Combination with Rifampin in Healthy Adult Volunteers.
    Benefield RJ; Slechta ES; Gast CM; Spivak ES; Hanson KE; Alexander DP
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects.
    Dvorchik BH; Brazier D; DeBruin MF; Arbeit RD
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1318-23. PubMed ID: 12654665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration.
    Wise R; Andrews JM; Marshall G; Hartman G
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1508-10. PubMed ID: 10348784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis.
    Salama NN; Segal JH; Churchwell MD; Patel JH; Gao L; Heung M; Mueller BA
    Clin J Am Soc Nephrol; 2009 Jul; 4(7):1190-4. PubMed ID: 19541812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections.
    Kullar R; Chin JN; Edwards DJ; Parker D; Coplin WM; Rybak MJ
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3505-9. PubMed ID: 21502620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pharmacokinetics of daptomycin in critically ill patients with renal failure and undergoing CVVHD.
    Khadzhynov D; Slowinski T; Lieker I; Spies C; Puhlmann B; König T; Uhrig A; Eggers K; Neumayer HH; Traunmüller F; Joukhadar C; Peters H
    Int J Clin Pharmacol Ther; 2011 Nov; 49(11):656-65. PubMed ID: 22011690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers.
    Benvenuto M; Benziger DP; Yankelev S; Vigliani G
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3245-9. PubMed ID: 17005801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified equations using two concentrations to calculate area under the curve for antimicrobials with concentration-dependent pharmacodynamics: daptomycin as a motivating example.
    Pai MP; Russo A; Novelli A; Venditti M; Falcone M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3162-7. PubMed ID: 24663017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.
    Bradley JS; Benziger D; Bokesch P; Jacobs R
    Pediatr Infect Dis J; 2014 Sep; 33(9):936-9. PubMed ID: 25361023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.